EP3329924
DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS
:
EP einkaleyfi: Þýðing ekki lögð inn:
29.3.2011:
5.5.2021:
17187246.8
:
28.3.2031
:
DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS
29.3.2011
5.5.2021
:
Alnylam Pharmaceuticals, Inc.:
300 Third Street, 3rd Floor, Cambridge, MA 02142, US
:
Kumamoto University:
39-1 Kurokami 2-chome, Kumamoto-shi Kumamoto 860-8555, JP
:
ALVAREZ, Rene:
Cambridge, MA 02142, US
:
SAH, Dinah Wen-Yee:
Cambridge, MA 02142, US
:
ANDO, Yukio:
Kumamoto 860-8555, JP
:
JONO, Hirofumi:
Kumamoto 860-8555, JP
:
318702 P:
29.3.2010:
US
:
318704 P:
29.3.2010:
US
:
A61K 31/7088, C07H 21/02, A61K 48/00, A61K 31/7115, A61K 31/713, C12N 15/113, A61P 27/02